OS Therapies raises $7.53M via warrant exercise inducement from all 9 existing holders

OS Therapies Inc

Gross proceeds of $7.53M from exercise or pre-funding of 5,382,148 Existing Warrants at $1.40/share.
New Warrants issued for up to 5,382,148 shares at $1.40, exercisable immediately for 5 years.
Net proceeds to fund OST-HER2 BLA/MMA filings, commercial prep, and OS Animal Health spinoff.
BLA for OST-HER2 in metastatic osteosarcoma expected by end of January 2026 under Accelerated Approval.
Company expects cash runway into 2027; all 9 accredited investors offered agreed to participate.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

OS Therapies Inc issued up to an aggregate of 5,382,148 shares of warrant to less than 10 accredited investors for $1.40 per share.

Security: warrant
Shares: up to an aggregate of 5,382,148 shares
Purchaser: less than 10 accredited investors
Consideration: $1.40 per share

Exact text from the filing

September 1, 2025 (the “Existing Warrants”). Pursuant to the Inducement Letters, the Holders agreed to exercise for cash their Existing Warrants at a reduced exercise price of $1.40 per share (the “Inducement Exercise Price”) in consideration of the Company’s agreement to issue new common stock purchase warrants (the “New Warrants”) to purchase up to an

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

OS Therapies Inc entered into Inducement Letters with less than 10 accredited investors valued at approximately $7.5 million (effective 2026-01-10).

Action: entry
Agreement: equity purchase
Counterparty: less than 10 accredited investors
Value: approximately $7.5 million
Effective: 2026-01-10

Exact text from the filing

On January 10, 2026, OS Therapies Incorporated (the “Company”) entered into inducement offer letter agreements (the “Inducement Letters”) with less than 10 accredited investors (the “Holders”)

View on SEC.gov

Browse all equity issuances →

OS Therapies Inc filing history →

Source: SEC EDGAR

accession 0001213900-26-003166

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.